As the economic outlook becomes gloomier and gloomier and the credit crunch bites even harder, experts at the Priory Group are warning that they are seeing an increasing number of patients suffering from the symptoms of ‘recession depression’.
People facing unemployment, mounting debts and losing their homes can be overwhelmed by negative feelings and this can manifest itself (more…)

ALK-Abell?? Ltd announced today that Grazax®, grass-pollen allergen tablet, is now available for use in children and adolescents aged 5 to 17.
Grazax is the only non-injection immunotherapy licensed to treat children suffering from severe grass pollen induced seasonal allergic rhinitis and conjunctivitis or severe hay fever1. In addition, it is the first immunotherapy tablet to address the underlying cause of grass pollen allergy2,3. It is a once daily (more…)

Humana Military Healthcare Services, TRICARE contractor for the South Region, is partnering with the University of Louisville to jointly sponsor a new continuing medical education course (CME) for physicians. Civilian providers throughout the country will have access to an online course on Post Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI).
" (more…)

Most of us remember our teenage years with a mix of fondness and relief. Fondness for the good memories, and relief that all that teenage stress, angst and drama - first love, gossip, SATs, fights with parents - is behind us.
Or is it? It turns out, say UCLA researchers, that even stressful times from the teenage years exact a physical toll that could have implications for health during adulthood.
Andrew J. Fuligni, a professor (more…)

Using sleep or napping to cope with chronic pain caused by tension-type headaches could lead to chronic insomnia according to a new study by researchers at Rush University Medical Center. The study, published in the February 15 issue of the Journal of Clinical Sleep Medicine, found that napping to relieve headache pain could serve as a behavioral link between headache and sleep disturbance.
The study compared a group of 32 women who were confirmed (more…)

VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated a second pivotal Phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting, (more…)

Men who experience erectile dysfunction between the ages of 40 and 49 are twice as likely to develop heart disease than men without dysfunction, according to a new Mayo Clinic study.
Researchers also found that men with erectile dysfunction have an 80 percent higher risk of heart disease.
"The highest risk for coronary heart disease was in younger men," says researcher Jennifer St. Sauver, (more…)

The National Breast Cancer Coalition Fund has awarded 20 Advocacy in Action grants totaling $100,000 to member organizations selected by a competitive application process to assist groups in forwarding advocacy locally.
"These grants offer our member organizations support as they work to (more…)

The conversation about male sexual dysfunction has grown from a whisper to a roar. From Bob Dole to Mike Ditka, erectile dysfunction, or ED, is no longer hush-hush as more men are talking more openly. Non-stop commercials convey help in the bedroom is just a prescription away. Generic synthroid pills no prescription (more…)

The snow is thawing, the first crocuses are fighting their way through the cold earth into the daylight and hay fever sufferers are already pulling out their handkerchiefs. A new type of measuring station will automatically determine the pollen count and thus improve the forecast.
"And here is the pollen forecast for tomorrow: Low levels of alder and hazel…" - we are all familiar with such reports from the radio and the television, (more…)